MyFinsight
Home
Blog
About
Accounts receivable,
related party
$287,147
(62.10%↑ Y/Y)
Cash
$239
(-86.43%↓ Y/Y)
Prepaid expenses
$200
(0.00%↑ Y/Y)
Total current assets
$287,587
(60.57%↑ Y/Y)
Total assets
$287,587
(46.10%↑ Y/Y)
Retained earnings
(deficit)
-$22,305,331
(-5.62%↓ Y/Y)
Other comprehensive
income
-$222,580
(-8.66%↓ Y/Y)
Total liabilities &
stockholders equity...
$287,587
(46.10%↑ Y/Y)
Total stockholders
equity (deficit)
-$5,878,206
(-1.07%↓ Y/Y)
Additional paid in capital
$16,521,226
(6.56%↑ Y/Y)
Common stock (.0001 par
value) 5,800,000,000...
$112,999
(3479.32%↑ Y/Y)
Preferred stock,
value-Series APreferred...
$15,475
(1430.66%↑ Y/Y)
Preferred stock,
value-Series MPreferred...
$3
(0.00%↑ Y/Y)
Preferred stock,
value-Series NCPreferred...
$2
(0.00%↑ Y/Y)
Total liabilities
$6,165,793
(2.55%↑ Y/Y)
Total current
liabilities
$6,165,793
(2.55%↑ Y/Y)
Accrued expenses
$2,007,987
(13.18%↑ Y/Y)
Derivative liability
$1,901,963
(6.83%↑ Y/Y)
Unearned income
$1,243,692
(-9.24%↓ Y/Y)
Convertible notes payable,
net of unamortized...
$726,291
(-5.66%↓ Y/Y)
Notes
payable-Nonrelated Party
$132,503
Other current
liabilities
$99,776
(375.12%↑ Y/Y)
Notes
payable-Related Party
$32,963
(-87.62%↓ Y/Y)
Accounts payable
$20,618
(-32.35%↓ Y/Y)
Back
Back
Balance Sheet
Regen BioPharma Inc (RGBP)
Regen BioPharma Inc (RGBP)
source: myfinsight.com